SCHEMBL21160844

SCHEMBL21160844

O=C1OC(C(=O)OCc2ccccc2)(C(=O)OCc2ccccc2)c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 1/20 0.45
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
ALDH1A1 P00352 6/20 0.44
CDC25B P30305 1/20 0.43
KMT2A Q03164 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CFTR P13569 1/20 0.41
GOPC Q9HD26 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6297178 0.84 DDB1 (0.46) CTRB1DDB1CRBNALDH1A1CDC25B
SCHEMBL6303522 0.83 DDB1 (0.42) CTRB1DDB1CRBNALDH1A1CDC25B
SCHEMBL4607575 0.83 ALDH1A1 (0.45) CTRB1DDB1CRBNALDH1A1CDC25B
SCHEMBL6299041 0.78 GAA (0.40) CTRB1DDB1CRBNALDH1A1CDC25B
SCHEMBL18663247 0.76 ALDH1A1 (0.50) CTRB1DDB1CRBNALDH1A1CDC25B
SCHEMBL8313978 0.71 SIGMAR1 (0.60) KMT2ANPSR1SMN1; SMN2NPC1RAB9A
SCHEMBL16034610 0.70 ALDH1A1 (0.46) CTRB1DDB1CRBNALDH1A1CDC25B
SCHEMBL5358863 0.68 KMT2A (0.54) DDB1CRBNALDH1A1KMT2ATDP1
SCHEMBL16661304 0.67 DDB1 (0.56) DDB1CRBNALDH1A1KMT2ATDP1
SCHEMBL20156647 0.67 DDB1 (0.46) DDB1CRBNALDH1A1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11215928-B2 Composition for resist underlayer film formation, resist underlayer film and method for forming the same, and production method of a patterned substrate JSR CORPORATION (JP) 2022-01-04 US disclosed
US-20190212650-A1 COMPOSITION FOR RESIST UNDERLAYER FILM FORMATION, RESIST UNDERLAYER FILM AND METHOD FOR FORMING THE SAME, AND PRODUCTION METHOD OF A PATTERNED SUBSTRATE JSR CORPORATION (JP) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11215928-B2 Composition for resist underlayer film formation, resist underlayer film and method for forming the same, and production method of a patterned substrate TOP1, OXA1L, RER1 CTRB1 2407/4885DDB1 2643/4885CRBN 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.